4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-040440
Chief Financial Officer acquired 193,254 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIRSKE DAVID Chief Financial Officer | 2025-08-14 | Grant or award | +193,254 | 193,254 | D | ||
| Derivatives | |||||||
| KIRSKE DAVID Chief Financial Officer | 2025-08-12 | Grant or award · Stock Option (right to buy) | +1,073,249 | 1,073,249 | D | ||
| KIRSKE DAVID Chief Financial Officer | 2025-08-14 | Grant or award · Stock Option (right to buy) | +352,800 | 352,800 | D | ||
Loading xslF345X05/wk-form4_1755217870.xml…